Free Trial

Regulus Therapeutics (RGLS) Institutional Ownership

Regulus Therapeutics logo
$1.95 +0.04 (+2.09%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$1.90 -0.05 (-2.62%)
As of 09:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Regulus Therapeutics (NASDAQ:RGLS)

Current
Institutional Ownership
Percentage
92.38%
Number of
Institutional Buyers
(last 12 months)
23
Total
Institutional Inflows
(last 12 months)
$72.62M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$17.32M
Get RGLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RGLS Institutional Buying and Selling by Quarter

Remove Ads

Regulus Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025Velan Capital Investment Management LP70,000$111K0.1%N/A0.107%
2/17/2025Octagon Capital Advisors LP4,848,802$7.66M1.3%+13.7%7.403%
2/17/2025Millennium Management LLC2,192,158$3.46M0.0%+69.7%3.347%
2/17/2025DAFNA Capital Management LLC875,200$1.38M0.4%-2.2%1.336%
2/14/2025RA Capital Management L.P.336,843$532K0.0%-56.1%0.514%
2/14/2025Northern Trust Corp457,233$722K0.0%-8.1%0.698%
2/14/2025Price T Rowe Associates Inc. MD29,597$47K0.0%-98.6%0.045%
2/13/2025PEAK6 LLC60,000$95K0.0%N/A0.092%
2/13/2025Barclays PLC96,247$152K0.0%+13.9%0.147%
2/13/2025Renaissance Technologies LLC117,100$185K0.0%+20.5%0.179%
2/12/2025JPMorgan Chase & Co.190,457$301K0.0%+141.2%0.291%
2/6/2025Victory Capital Management Inc.389,886$616K0.0%-2.3%0.595%
1/30/2025 Rhumbline Advisers59,531$94K0.0%-20.1%0.091%
12/26/2024JPMorgan Chase & Co.78,972$124K0.0%+193.4%0.121%
11/19/2024Barclays PLC84,477$132K0.0%+285.2%0.129%
11/16/2024Geode Capital Management LLC1,280,567$2.01M0.0%-4.0%1.955%
11/15/2024Barclays PLC84,477$132K0.0%+285.2%0.129%
11/15/2024Jane Street Group LLC29,580$46K0.0%N/A0.045%
11/15/2024State Street Corp1,000,998$1.57M0.0%+3.5%1.528%
11/15/2024RA Capital Management L.P.766,834$1.20M0.0%-87.7%1.171%
11/15/2024Point72 Asset Management L.P.893,762$1.40M0.0%N/A1.365%
11/14/2024NEA Management Company LLC6,467,802$10.15M0.6%N/A9.875%
11/13/2024FMR LLC328,157$515K0.0%-83.8%0.501%
11/13/2024The Manufacturers Life Insurance Company129,700$204K0.0%N/A0.198%
11/5/2024Victory Capital Management Inc.398,866$626K0.0%+10.4%0.609%
10/25/2024Tyche Wealth Partners LLC106,089$167K0.0%+920.6%0.162%
10/11/2024Creative Planning16,466$26K0.0%N/A0.025%
10/3/2024SG Americas Securities LLC20,800$33K0.0%N/A0.032%
8/15/2024CVI Holdings LLC401,012$716K0.6%-71.5%0.613%
8/9/2024Renaissance Technologies LLC118,100$211K0.0%+56.4%0.180%
8/5/2024Victory Capital Management Inc.361,386$645K0.0%-1.8%0.552%
8/1/2024 Rhumbline Advisers76,472$136K0.0%N/A0.117%
7/26/2024Bank of New York Mellon Corp197,193$352K0.0%N/A0.301%
5/29/2024Opaleye Management Inc.170,308$490K0.1%N/A0.260%
5/17/2024RA Capital Management L.P.6,250,000$18M0.2%N/A9.547%
5/15/2024NEA Management Company LLC6,467,802$18.63M1.1%N/A9.879%
5/10/2024Vanguard Group Inc.740,215$2.13M0.0%+158.4%1.131%
5/7/2024CVI Holdings LLC1,406,250$4.05M3.9%N/A2.148%
4/22/2024Vivo Capital LLC5,000,000$14.40M1.1%N/A7.638%
2/5/2024Victory Capital Management Inc.271,736$348K0.0%+16.5%1.344%
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
11/13/2023FMR LLC2,922,600$4.03M0.0%+32.4%14.454%
11/6/2023Victory Capital Management Inc.233,207$322K0.0%+5.3%1.197%
8/14/2023Prelude Capital Management LLC40,660$60K0.0%N/A0.209%
9/16/2022Federated Hermes Inc.2,904,826$6.01M0.0%-90.0%19.850%
8/16/2022DAFNA Capital Management LLC555,555$1.15M0.3%-90.0%3.797%
8/12/2022Ikarian Capital LLC105,341$217K0.0%-91.8%0.722%
8/1/2022Victory Capital Management Inc.221,506$459K0.0%-90.1%1.517%
7/19/2022Commonwealth Equity Services LLC22,000$45K0.0%-83.2%0.151%
2/14/2022DAFNA Capital Management LLC5,555,555$1.75M0.4%N/A6.382%
1/19/2022Asymmetry Capital Management L.P.2,731,044$860K0.5%+94.9%3.137%
11/15/2021GSA Capital Partners LLP64,708$45K0.0%-68.6%0.074%
11/4/2021Asymmetry Capital Management L.P.1,401,491$968K0.6%-3.4%1.610%
10/29/2021Commonwealth Equity Services LLC111,000$76K0.0%+38.8%0.128%
9/17/2021Virtu Financial LLC79,193$64K0.0%N/A0.091%
8/27/2021Endurant Capital Management LP2,607,674$2.12M0.6%+9.7%2.996%
8/16/2021State Street Corp176,494$144K0.0%N/A0.203%
8/13/2021Geode Capital Management LLC589,196$479K0.0%+54.3%0.786%
8/13/2021Vanguard Group Inc.3,095,237$2.52M0.0%-3.9%4.131%
8/12/2021Lido Advisors LLC57,500$47K0.0%N/A0.077%
8/11/2021Commonwealth Equity Services LLC80,000$65K0.0%+300.0%0.107%
8/10/2021Strategic Wealth Advisors Group LLC74,800$61K0.0%N/A0.100%
8/5/2021GSA Capital Partners LLP206,265$168K0.0%N/A0.275%
7/31/2021Asymmetry Capital Management L.P.1,450,777$1.18M0.8%-26.9%1.936%
7/15/2021Focused Wealth Management Inc200,000$163K0.0%+100.0%0.267%
5/19/2021Squarepoint Ops LLC159,804$249K0.0%+1,477.7%0.213%
5/17/2021Endurant Capital Management LP2,376,557$3.71M1.0%N/A3.172%
5/17/2021Ikarian Capital LLC1,245,989$1.94M0.1%N/A1.663%
5/17/2021Atom Investors LP337,228$526K0.1%N/A0.450%
5/17/2021Goldman Sachs Group Inc.18,049$28K0.0%-68.0%0.024%
5/12/2021Northern Trust Corp117,654$184K0.0%+198.4%0.157%
5/12/2021Geode Capital Management LLC381,892$595K0.0%+493.5%0.510%
5/11/2021Acadian Asset Management LLC465,678$726K0.0%N/A0.622%
5/11/2021Asymmetry Capital Management L.P.1,985,472$3.10M1.6%N/A2.650%
5/4/2021Commonwealth Equity Services LLC20,000$31K0.0%N/A0.027%
5/4/2021Victory Capital Management Inc.2,227,199$3.47M0.0%+345.4%2.976%
5/3/2021Focused Wealth Management Inc100,000$156K0.0%N/A0.134%
(Data available from 1/1/2016 forward)

Remove Ads

RGLS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RGLS shares?

During the previous two years, 29 institutional investors and hedge funds held shares of Regulus Therapeutics. The most heavily invested institutionals were Vivo Capital LLC ($14.40M), NEA Management Company LLC ($10.15M), Octagon Capital Advisors LP ($7.66M), Millennium Management LLC ($3.46M), Vanguard Group Inc. ($2.13M), Geode Capital Management LLC ($2.01M), and State Street Corp ($1.57M).Learn more on RGLS's institutional investors.

What percentage of Regulus Therapeutics stock is owned by institutional investors?

92.38% of Regulus Therapeutics stock is owned by institutional investors. Learn more on RGLS's institutional investor holdings.

Which institutional investors have been buying Regulus Therapeutics stock?

Of the 25 institutional investors that purchased Regulus Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: NEA Management Company LLC ($12.94M), RA Capital Management L.P. ($6.25M), Vivo Capital LLC ($5M), CVI Holdings LLC ($1.41M), Millennium Management LLC ($900.74K), Point72 Asset Management L.P. ($893.76K), and FMR LLC ($716K).

How much institutional buying is happening at Regulus Therapeutics?

Institutional investors have bought a total of 30,532,235 shares in the last 24 months. This purchase volume represents approximately $73.73M in transactions.

Which Regulus Therapeutics major shareholders have been selling company stock?

Of the 9 institutional investors that sold Regulus Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($5.91M), Price T Rowe Associates Inc. MD ($2.12M), FMR LLC ($1.69M), CVI Holdings LLC ($1.01M), Geode Capital Management LLC ($52.94K), Northern Trust Corp ($40.07K), and DAFNA Capital Management LLC ($20K).

How much institutional selling is happening at Regulus Therapeutics?

Institutional investors have sold a total of 10,878,029 shares in the last 24 months. This volume of shares sold represents approximately $17.32M in transactions.



This page (NASDAQ:RGLS) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners